Ocean Bio-Chem EPS
The Earnings per Share (EPS) of Ocean Bio-Chem (OBCI) as of Nov 1, 2026 is 0.93 USD. In the previous year, Earnings per Share (EPS) was 1.07 USD — a change of -12.61% (lower).
Get this data via API
Financial Data API
EPS
0.93USD
YoY
-12.61%
Last updated:
The Ocean Bio-Chem EPS history
3 Years
10 Years
25 Years
Max
| YEAR | EPS | YoY |
|---|---|---|
| 0.93USD | -12.61% | |
| 1.07USD | +174.86% | |
| 0.39USD | +25.17% | |
| 0.31USD | +7.36% | |
| 0.29USD | +24.26% | |
| 0.23USD | +354.79% | |
| 0.05USD | -77.51% | |
| 0.23USD | +40.18% | |
| 0.16USD | -25.55% | |
| 0.22USD | -27.10% | |
| 0.30USD | +25.13% | |
| 0.24USD | +74.63% | |
| 0.14USD | +594.88% | |
| 0.02USD | -76.02% | |
| 0.08USD | +64.28% | |
| 0.05USD | -116.13% | |
| -0.31USD | -1,650.00% | |
| 0.02USD | -71.43% | |
| 0.07USD | +133.33% | |
| 0.03USD | — |
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Ocean Bio-Chem Stock analysis
Frequently Asked Questions about Ocean Bio-Chem stock
Earnings per Share (EPS) of Ocean Bio-Chem is 0.93 USD in 2021.
Earnings per Share (EPS) of Ocean Bio-Chem changed from 1.07 USD to 0.93 USD, representing a -12.61% change. The value is lower than the previous year.
On Eulerpool you can find the complete historical development of Earnings per Share (EPS) Ocean Bio-Chem since 2006 – with annual values, charts, and detailed analysis.
Earnings per Share measures the portion of a company's profit allocated to each outstanding share. It is a key metric for assessing a company's profitability on a per-share basis.
EPS = Net Income / Shares Outstanding
Access this data via the Eulerpool API
100,000 free requests/mo · no credit card
Income Statement — Ocean Bio-Chem
All Key Metrics — Ocean Bio-Chem
Valuation
Income Statement
Margins
Balance Sheet
- Total Assets
- Current Assets
- Cash & Equivalents
- Receivables
- Inventory
- Property, Plant & Equipment
- Goodwill
- Intangible Assets
- Equity
- Liabilities
- Debt
- Current Liabilities
- Long-term Debt
- Short-term Debt
- Retained Earnings
- Book Value per Share
- Tangible Book Value per Share
- Working Capital
- Investments
- Accounts Payable
- Non-Current Assets
- Short-Term Investments
- Long-Term Investments
- Net Debt
- Treasury Stock
- Minority Interest
- Deferred Tax Liabilities
- Net Tangible Assets
- Goodwill/Assets
- Intangibles/Assets
Cash Flow
- Operating Cash Flow
- Capital Expenditures
- Free Cash Flow
- FCF per Share
- Dividends Paid
- Share Buybacks
- Investing Cash Flow
- Financing Cash Flow
- CapEx / Revenue
- Cash Flow per Share
- Stock-Based Compensation
- Change in Working Capital
- Acquisitions (Net)
- Net Change in Cash
- CapEx/OCF
- FCF/Net Income
- FCF Conversion
- Cash Conversion
- Total Shareholder Payout
- CapEx/D&A
Profitability
- ROE
- ROA
- ROCE
- ROIC
- Asset Turnover
- Inventory Turnover
- Receivables Turnover
- Days Sales Outstanding
- Days Inventory Outstanding
- Days Payable Outstanding
- Cash Conversion Cycle
- CROIC
- Gross Profit/Assets
- Fixed Asset Turnover
- Equity Turnover
- Working Capital Turnover
- Payables Turnover
- Capital Intensity
- Receivables/Revenue
- Inventory/Revenue
- EBIT/Assets
Leverage
Growth
- Revenue Growth
- Revenue CAGR 3Y
- Revenue CAGR 5Y
- Revenue CAGR 10Y
- Earnings Growth
- EPS Growth
- EBIT Growth
- EBIT CAGR 3Y
- EBIT CAGR 5Y
- EBIT CAGR 10Y
- Dividend Growth
- FCF Growth
- Book Value Growth
- Earnings CAGR 3Y
- Earnings CAGR 5Y
- Earnings CAGR 10Y
- EPS CAGR 3Y
- EPS CAGR 5Y
- EBITDA Growth YoY
- EBITDA CAGR 3Y
- EBITDA CAGR 5Y
- Gross Profit Growth
- OCF Growth YoY
- Employee Growth
- Dividend CAGR 3Y
- Dividend CAGR 5Y
- Dividend CAGR 10Y
- Asset Growth
- Equity Growth
- Debt Growth
- CapEx Growth
- FCF CAGR 3Y
- FCF CAGR 5Y
- Market Cap Growth
- Share Count Growth